Skip to main content
. 2022 Nov 25;14(23):5803. doi: 10.3390/cancers14235803

Figure 1.

Figure 1

Kaplan–Meier estimates of biochemical recurrence-free survival according to the National Comprehensive Cancer Network risk stratification. The 2-year BRFS rates in the low-, intermediate-, and high-risk groups were 98.8%, 94.9%, and 91.2%, respectively.